Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project

Fig. 2

In-hospital outcomes within 15 days after hospitalization. The incidence of in-hospital primary effectiveness outcomes [major adverse cardiovascular event (MACE)] (A) and all cause death (B) were higher in the non-reloading group compared with reloading group in NSTEACS study population. The incidence of both MI (C) and major bleeding (D) were no statistically significant difference compared with the non-reloading group in both the whole study population

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us